메뉴 건너뛰기




Volumn 141, Issue 6, 2017, Pages 1190-1200

uPA/uPAR system activation drives a glycolytic phenotype in melanoma cells

Author keywords

cancer cell metabolism; melanoma cells; uPA uPAR system

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CD147 ANTIGEN; DEGENERATED OLIGODEOXYNUCLEOTIDE; ENOLASE; EPIDERMAL GROWTH FACTOR RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTEGRIN LINKED KINASE; M25 PEPTIDE; MAMMALIAN TARGET OF RAPAMYCIN; OLIGODEOXYNUCLEOTIDE; PEPTIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PYRUVATE KINASE; SMALL INTERFERING RNA; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN; UROKINASE; UROKINASE RECEPTOR; VERY LATE ACTIVATION ANTIGEN 5; PLAUR PROTEIN, HUMAN;

EID: 85021206266     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.30817     Document Type: Article
Times cited : (39)

References (44)
  • 1
    • 66249108601 scopus 로고    scopus 로고
    • Understanding the Warburg effect: the metabolic requirements of cell proliferation
    • Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009; 324:1029–33
    • (2009) Science , vol.324 , pp. 1029-1033
    • Vander Heiden, M.G.1    Cantley, L.C.2    Thompson, C.B.3
  • 2
    • 70350743151 scopus 로고    scopus 로고
    • 18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization
    • Jadvar H, Alavi A, Gambhir SS. 18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization. J Nucl Med 2009; 50:1820–7.
    • (2009) J Nucl Med , vol.50 , pp. 1820-1827
    • Jadvar, H.1    Alavi, A.2    Gambhir, S.S.3
  • 3
    • 35448940364 scopus 로고    scopus 로고
    • Adaptive landscapes and emergent phenotypes: why do cancers have high glycolysis?
    • Gillies RJ, Gatenby RA. Adaptive landscapes and emergent phenotypes: why do cancers have high glycolysis? J Bioenerg Biomembr 2007; 39:251–7.
    • (2007) J Bioenerg Biomembr , vol.39 , pp. 251-257
    • Gillies, R.J.1    Gatenby, R.A.2
  • 7
    • 84905096091 scopus 로고    scopus 로고
    • Extracellular acidity, a “reappreciated” trait of tumor environment driving malignancy: perspectives in diagnosis and therapy
    • Peppicelli S, Bianchini F, Calorini L. Extracellular acidity, a “reappreciated” trait of tumor environment driving malignancy: perspectives in diagnosis and therapy. Cancer Metastasis Rev 2014; 33:823–32.
    • (2014) Cancer Metastasis Rev , vol.33 , pp. 823-832
    • Peppicelli, S.1    Bianchini, F.2    Calorini, L.3
  • 8
    • 84883182637 scopus 로고    scopus 로고
    • Disrupting proton dynamics and energy metabolism for cancer therapy
    • Parks SK, Chiche J, Pouysségur J. Disrupting proton dynamics and energy metabolism for cancer therapy. Nat Rev Cancer 2013; 13:611–23.
    • (2013) Nat Rev Cancer , vol.13 , pp. 611-623
    • Parks, S.K.1    Chiche, J.2    Pouysségur, J.3
  • 9
    • 33646917296 scopus 로고    scopus 로고
    • The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism
    • Ullah MS, Davies AJ, Halestrap AP. The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism. J Biol Chem 2006; 281:9030–7.
    • (2006) J Biol Chem , vol.281 , pp. 9030-9037
    • Ullah, M.S.1    Davies, A.J.2    Halestrap, A.P.3
  • 10
    • 58249094845 scopus 로고    scopus 로고
    • Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH
    • Chiche J, Ilc K, Laferrière J, Trottier E, Dayan F, Mazure NM, Brahimi-Horn MC, Pouysségur J. Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH. Cancer Res 2009; 69:358–68.
    • (2009) Cancer Res , vol.69 , pp. 358-368
    • Chiche, J.1    Ilc, K.2    Laferrière, J.3    Trottier, E.4    Dayan, F.5    Mazure, N.M.6    Brahimi-Horn, M.C.7    Pouysségur, J.8
  • 13
    • 0032079312 scopus 로고    scopus 로고
    • Hypoxia stimulates urokinase receptor expression through a heme protein-dependent pathway
    • Graham CH, Fitzpatrick TE, McCrae KR. Hypoxia stimulates urokinase receptor expression through a heme protein-dependent pathway. Blood 1998; 91:3300–7
    • (1998) Blood , vol.91 , pp. 3300-3307
    • Graham, C.H.1    Fitzpatrick, T.E.2    McCrae, K.R.3
  • 14
    • 0033521864 scopus 로고    scopus 로고
    • Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression
    • Graham CH, Forsdike J, Fitzgerald CJ, Macdonald-Goodfellow S. Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression. Int J Cancer 1999; 80:617–23
    • (1999) Int J Cancer , vol.80 , pp. 617-623
    • Graham, C.H.1    Forsdike, J.2    Fitzgerald, C.J.3    Macdonald-Goodfellow, S.4
  • 16
    • 0037086083 scopus 로고    scopus 로고
    • Hypoxia promotes lymph node metastasis in human melanoma xenografts by up-regulating the urokinase-type plasminogen activator receptor
    • Rofstad EK, Rasmussen H, Galappathi K, Mathiesen B, Nilsen K, Graff BA. Hypoxia promotes lymph node metastasis in human melanoma xenografts by up-regulating the urokinase-type plasminogen activator receptor. Cancer Res 2002; 62:1847–53
    • (2002) Cancer Res , vol.62 , pp. 1847-1853
    • Rofstad, E.K.1    Rasmussen, H.2    Galappathi, K.3    Mathiesen, B.4    Nilsen, K.5    Graff, B.A.6
  • 17
    • 1642535600 scopus 로고    scopus 로고
    • Increased metastatic dissemination in human melanoma xenografts after sub-curative radiation treatment: radiation-induced increase in fraction of hypoxic cells and hypoxia-induced up-regulation of urokinase-type plasminogen activator receptor
    • Rofstad EK, Mathiesen B, Galappathi K. Increased metastatic dissemination in human melanoma xenografts after sub-curative radiation treatment: radiation-induced increase in fraction of hypoxic cells and hypoxia-induced up-regulation of urokinase-type plasminogen activator receptor. Cancer Res 2004; 64:13–8.
    • (2004) Cancer Res , vol.64 , pp. 13-18
    • Rofstad, E.K.1    Mathiesen, B.2    Galappathi, K.3
  • 18
    • 0030982781 scopus 로고    scopus 로고
    • Interaction of urokinase-type plasminogen activator with its receptor rapidly induces activation of glucose transporters
    • Anichini E, Zamperini A, Chevanne M, Caldini R, Pucci M, Fibbi G, Del Rosso M. Interaction of urokinase-type plasminogen activator with its receptor rapidly induces activation of glucose transporters. Biochemistry 1997; 36:3076–83.
    • (1997) Biochemistry , vol.36 , pp. 3076-3083
    • Anichini, E.1    Zamperini, A.2    Chevanne, M.3    Caldini, R.4    Pucci, M.5    Fibbi, G.6    Del Rosso, M.7
  • 20
    • 58149172000 scopus 로고    scopus 로고
    • Apigenin inhibits the GLUT-1 glucose transporter and the phosphoinositide 3-kinase/Akt pathway in human pancreatic cancer cells
    • Melstrom LG, Salabat MR, Ding XZ, Milam BM, Strouch M, Pelling JC, Bentrem DJ. Apigenin inhibits the GLUT-1 glucose transporter and the phosphoinositide 3-kinase/Akt pathway in human pancreatic cancer cells. Pancreas 2008; 37:426–31.
    • (2008) Pancreas , vol.37 , pp. 426-431
    • Melstrom, L.G.1    Salabat, M.R.2    Ding, X.Z.3    Milam, B.M.4    Strouch, M.5    Pelling, J.C.6    Bentrem, D.J.7
  • 21
    • 80053421131 scopus 로고    scopus 로고
    • Endothelial progenitor cell-dependent angiogenesis requires localization of the full-length form of uPAR in caveolae
    • Margheri F, Chillà A, Laurenzana A, et al. Endothelial progenitor cell-dependent angiogenesis requires localization of the full-length form of uPAR in caveolae. Blood 2011; 118:3743–55.
    • (2011) Blood , vol.118 , pp. 3743-3755
    • Margheri, F.1    Chillà, A.2    Laurenzana, A.3
  • 22
    • 84904258144 scopus 로고    scopus 로고
    • The receptor for urokinase-plasminogen activator (uPAR) controls plasticity of cancer cell movement in mesenchymal and amoeboid migration style
    • Mar 30;
    • Margheri F, Luciani C, Taddei ML, et al. The receptor for urokinase-plasminogen activator (uPAR) controls plasticity of cancer cell movement in mesenchymal and amoeboid migration style. Oncotarget 2014 Mar 30; 5:1538–53.
    • (2014) Oncotarget , vol.5 , pp. 1538-1553
    • Margheri, F.1    Luciani, C.2    Taddei, M.L.3
  • 23
    • 84869069142 scopus 로고    scopus 로고
    • Cell surface remodeling by plasmin: a new function for an old enzyme
    • Deryugina EI, Quigley JP. Cell surface remodeling by plasmin: a new function for an old enzyme. J Biomed Biotechnol 2012; 2012:564259
    • (2012) J Biomed Biotechnol , vol.2012 , pp. 564259
    • Deryugina, E.I.1    Quigley, J.P.2
  • 24
    • 13844296556 scopus 로고    scopus 로고
    • Roles of the multifunctional glycoprotein, emmprin (basigin; CD147), in tumour progression
    • Yan L, Zucker S, Toole BP. Roles of the multifunctional glycoprotein, emmprin (basigin; CD147), in tumour progression. Thromb Haemost 2005; 93:199–204.
    • (2005) Thromb Haemost , vol.93 , pp. 199-204
    • Yan, L.1    Zucker, S.2    Toole, B.P.3
  • 25
    • 33745303045 scopus 로고    scopus 로고
    • Hypoxia signalling in cancer and approaches to enforce tumor regression
    • Pouyssegur J, Dayan F, Mazure NM. Hypoxia signalling in cancer and approaches to enforce tumor regression. Nature 2006; 441:437–43.
    • (2006) Nature , vol.441 , pp. 437-443
    • Pouyssegur, J.1    Dayan, F.2    Mazure, N.M.3
  • 26
    • 50149097983 scopus 로고    scopus 로고
    • Hyopxia, HIF1 and glucose metabolism in the solid tumor
    • Denko NC. Hyopxia, HIF1 and glucose metabolism in the solid tumor. Nat Rev Cancer 2008; 8:705–13.
    • (2008) Nat Rev Cancer , vol.8 , pp. 705-713
    • Denko, N.C.1
  • 27
    • 2942724235 scopus 로고    scopus 로고
    • mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways
    • Majumder PK, Febbo PG, Bikoff R, et al. mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways. Nat Med 2004; 10:594–601.
    • (2004) Nat Med , vol.10 , pp. 594-601
    • Majumder, P.K.1    Febbo, P.G.2    Bikoff, R.3
  • 28
    • 0142166332 scopus 로고    scopus 로고
    • Targeting HIF-1 for cancer therapy
    • Semenza GL. Targeting HIF-1 for cancer therapy. Nature Rev Cancer 2003; 3:721–32.
    • (2003) Nature Rev Cancer , vol.3 , pp. 721-732
    • Semenza, G.L.1
  • 31
    • 78650801365 scopus 로고    scopus 로고
    • Downregulation of uPAR inhibits migration, invasion, proliferation, FAK/PI3K/Akt signaling and induces senescence in papillary thyroid carcinoma cells
    • Nowicki TS, Zhao H, Darzynkiewicz Z, Moscatello A, Shin E, Schantz S, Tiwari RK, Geliebter J. Downregulation of uPAR inhibits migration, invasion, proliferation, FAK/PI3K/Akt signaling and induces senescence in papillary thyroid carcinoma cells. Cell Cycle 2011; 10:100–7.
    • (2011) Cell Cycle , vol.10 , pp. 100-107
    • Nowicki, T.S.1    Zhao, H.2    Darzynkiewicz, Z.3    Moscatello, A.4    Shin, E.5    Schantz, S.6    Tiwari, R.K.7    Geliebter, J.8
  • 34
    • 18944401136 scopus 로고    scopus 로고
    • Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide
    • Llinas P, Le Du MH, Gardsvoll H, Dano K, Ploug M, Gilquin B, Stura EA, Ménez A. Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide. Embo J 2005; 24:1655–63.
    • (2005) Embo J , vol.24 , pp. 1655-1663
    • Llinas, P.1    Le Du, M.H.2    Gardsvoll, H.3    Dano, K.4    Ploug, M.5    Gilquin, B.6    Stura, E.A.7    Ménez, A.8
  • 35
    • 0032564309 scopus 로고    scopus 로고
    • Identification of specific sites involved in ligand binding by photoaffinity labeling of the receptor for the urokinase-type plasminogen activator. Residues located at equivalent positions in uPAR domains I and III participate in the assembly of a composite ligand-binding site
    • Ploug M. Identification of specific sites involved in ligand binding by photoaffinity labeling of the receptor for the urokinase-type plasminogen activator. Residues located at equivalent positions in uPAR domains I and III participate in the assembly of a composite ligand-binding site. Biochemistry 1998; 37:16494–505.
    • (1998) Biochemistry , vol.37 , pp. 16494-16505
    • Ploug, M.1
  • 36
    • 0346736507 scopus 로고    scopus 로고
    • The cleavage of the urokinase receptor regulates its multiple functions
    • Montuori N, Carriero MV, Salzano S, Rossi G, Ragno P. The cleavage of the urokinase receptor regulates its multiple functions. J Biol Chem 2002; 277:46932–9.
    • (2002) J Biol Chem , vol.277 , pp. 46932-46939
    • Montuori, N.1    Carriero, M.V.2    Salzano, S.3    Rossi, G.4    Ragno, P.5
  • 39
    • 84875459340 scopus 로고    scopus 로고
    • Proliferation-independent control of tumor glycolysis by PDGFR-mediated AKT activation
    • Ran C, Liu H, Hitoshi Y, Israel MA. Proliferation-independent control of tumor glycolysis by PDGFR-mediated AKT activation. Cancer Res 2013; 73:1831–43.
    • (2013) Cancer Res , vol.73 , pp. 1831-1843
    • Ran, C.1    Liu, H.2    Hitoshi, Y.3    Israel, M.A.4
  • 41
    • 46649121742 scopus 로고    scopus 로고
    • Hepatocyte growth factor is a novel stimulator of glucose uptake and metabolism in skeletal muscle cells
    • Perdomo G, Martinez-Brocca MA, Bhatt BA, Brown NF, O'Doherty RM, Garcia OA. Hepatocyte growth factor is a novel stimulator of glucose uptake and metabolism in skeletal muscle cells. J Biol Chem 2008; 283:13700–6.
    • (2008) J Biol Chem , vol.283 , pp. 13700-13706
    • Perdomo, G.1    Martinez-Brocca, M.A.2    Bhatt, B.A.3    Brown, N.F.4    O'Doherty, R.M.5    Garcia, O.A.6
  • 42
    • 0036596352 scopus 로고    scopus 로고
    • EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma
    • Liu D, Aguirre Ghiso JA, Estrada Y, Ossowski L. EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma. Cancer Cell 2002; 1:445–457.
    • (2002) Cancer Cell , vol.1 , pp. 445-457
    • Liu, D.1    Aguirre Ghiso, J.A.2    Estrada, Y.3    Ossowski, L.4
  • 43
    • 0037379794 scopus 로고    scopus 로고
    • ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK)
    • Aguirre-Ghiso JA, Estrada Y, Liu D, Ossowski L. ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK). Cancer Res 2003; 63:1684–95.
    • (2003) Cancer Res , vol.63 , pp. 1684-1695
    • Aguirre-Ghiso, J.A.1    Estrada, Y.2    Liu, D.3    Ossowski, L.4
  • 44
    • 84963625116 scopus 로고    scopus 로고
    • The role of Akt pathway signaling in glucose metabolism and metabolic oxidative stress
    • In, Spitz DR, Dornfeld KJ, Krishnan K, Gius D, eds., New York, Springer Science & Business Media
    • Simons AL, Orcutt KP, Madsen JM, Scarbrough PM, Spitz DR. The role of Akt pathway signaling in glucose metabolism and metabolic oxidative stress. In: Spitz DR, Dornfeld KJ, Krishnan K, Gius D, eds. Oxidative stress in cancer biology and therapy. New York: Springer Science & Business Media, 2012. 21–46.
    • (2012) Oxidative stress in cancer biology and therapy , pp. 21-46
    • Simons, A.L.1    Orcutt, K.P.2    Madsen, J.M.3    Scarbrough, P.M.4    Spitz, D.R.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.